The US Patent Office issues new patents every Tuesday. Australian assignees generally get two or three healthcare and biotech-related patents a week. Here are the 136 US patents relevant to Australia's Life Sciences sector that issued between 6 January 2015 and 29 December 2015, for an issuance rate of 2.6 per week. For patents issued in the last twelve months click here.
US Patent 9,221,799 |
Description: This patent covers analogus of the marine alkaloid naamidine A, which is an antagonist of the Epidermal Growth Factor Receptor.
|
US Patent 9,220,928 |
Title: Plant extracts from Acronychia species and their use
Issued: 29 December 2015 Assignee: EcoBiotics |
Description: This patent covers natural products derived from a rainforest treet native to north Queensland called the lemon aspen (Acronychia acidula).
|
US Patent 9,220,806 |
Title: Biocompatible material and uses thereof
Issued: 29 December 2015 Assignee: University of Sydney |
Description: This patent covers a biocompatible ceramic made of doped calcium zinc silicate and a metal oxide useful in tissue regeneration.
|
US Patent 9,220,724 |
Title: MicroRNA-based approach to treating malignant pleural mesothelioma
Issued: 29 December 2015 Assignee: Asbestos Diseases Research Institute |
Description: This patent covers microRNA mimics, corresponding to the miR-15/107 family potentially useful in the treatment of mesothelioma.
|
US Patent 9,220,678 |
Description: This patent covers a method of coating bioactives onto projections from a patch.
|
US Patent 9,211,331 |
Description: This patent covers natural alumino-silicate minerals used in animal husbandry which have been irradiated to improve bioavailability.
|
US Patent 9,211,329 |
Title: Method of treating inflammatory bowel disease
Issued: 15 December 2015 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers the use of GM-CSF inhibitors in the treatment of inflammatory bowel disease.
|
US Patent 9,211,237 |
Title: Film foaming hydroalcoholic foam
Issued: 15 December 2015 Assignee: Stiefel Research Australia |
Description: This patent covers a water-resistant sunscreen.
|
US Patent 9,206,171 |
Title: 6-{2 -[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzi- soxazole bis-dihydrogenphosphate salt (1:2)
Issued: 8 December 2015 Assignee: Biota |
Description: This patent covers composition of matter over Biota's human rhinovirus drug.
|
US Patent 9,205,121 |
Description: This patent covers a formulation of Echinacea that better metabolise the alkylamides that can macrophage immune responses.
|
US Patent 9,200,020 |
Title: 6-oxopurine phosphoribosyltransferase inhibitors
Issued: 1 December 2015 Assignee: University of Queensland (50%), Institute of Organic Chemistry and Biochemistry (Czechia, 50%) |
Description: This patent covers a potential new malaria drug.
|
US Patent 9,199,976 |
Title: Haematopoietic-prostaglandin D2 synthase inhibitors
Issued: 1 December 2015 Assignee: University of Queensland |
Description: This patent covers a prostaglandin inhibitor that would work without the side effects of cyclooxygenase inhibition.
|
US Patent 9,193,716 |
Description: This patent covers a Sphingosine 1-phosphate (S1P) modulator for anti-inflammatory applications.
|
US Patent 9,186,404 |
Title: Brain, spinal and nerve injury treatment
Issued: 17 November 2015 Assignee: Eustralis Pharmaceuticals |
Description: This patent covers Substance P receptor antagonists.
|
US Patent 9,186,321 |
Title: Oral spray formulations and methods for administration of sildenafil
Issued: 17 November 2015 Assignee: Suda Ltd (ASX: SUD) |
Description: This patent covers delivery of Viagra via a buccal spray.
|
US Patent 9,181,320 |
Title: Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor
Issued: 10 November 2015 Assignee: Biosceptre International |
Description: This patent covers antibodies to P2X7 receptors where those receptors are not functional.
|
US Patent 9,180,194 |
Title: Method and composition for transdermal drug delivery
Issued: 10 November 2015 Assignee: Acrux (ASX: ACR) |
Description: This patent covers Acrux's Axiron testosterone spray formulation.
|
US Patent 9,175,279 |
Title: Method of purifying factor VII and/or factor VIIa
Issued: 3 November 2015 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers a new method for making Factor VII.
|
US Patent 9,174,982 |
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Issued: 3 November 2015 Assignee: Walter and Eliza Hall Institute (33%), AbbVie (US, 33%), Genentech (US, 33%) |
Description: This patent covers small molecules that inhibit anti-apoptotic Bcl-2 proteins.
|
US Patent 9,173,911 |
Title: Method for producing vegetable cell sap concentrate and means for the production thereof
Issued: 3 November 2015 Assignee: Solagran (50%), SibEX (Russia, 50%) |
Description: This patent covers the use of liquefied carbonic acid to extract vegetable sap.
|
US Patent 9,173,866 |
Title: Compositions and products containing R-equol, and methods for their making
Issued: 3 November 2015 Assignee: Sanitarium (50%), Cincinnati Children's Hospital (United States, 50%) |
Description: This patent covers R-equol, an intestinally derived metabolite of the soy isoflavone daidzein. R-equol may be useful in enhancing the efficacy of soy diets.
|
US Patent 9,169,495 |
Title: Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
Issued: 27 October 2015 Assignee: EnGeneIC |
Description: This patent covers methods to deliver EnGeneIC's minicells into non-phagocytic cells, such as breast cancer cells.
|
US Patent 9,169,329 |
Title: Antibodies directed to the receptor tyrosine kinase c-Met
Issued: 27 October 2015 Assignee: Monash University (50%), Ludwig Institute for Cancer Research (US, 50%) |
Description: This patent covers antibodies to the cancer target c-Met.
|
US Patent 9,169,211 |
Title: 8-hydroxy quinoline derivatives
Issued: 27 October 2015 Assignee: Prana Biotechnology (ASX: PBT) |
Description: This patent covers a suite of metal-protein attenuating compounds useful in treating Alzheimer's.
|
US Patent 9,168,302 |
Title: Reduction of side effects from aromatase inhibitors used for treating breast cancer
Issued: 27 October 2015 Assignee: Chavah Pty Ltd |
Description: This patent covers the use of testosterone and anastrozole to reduce mammographic breast density, improving the ability to detect breast cancer with mammograms.
|
US Patent 9,168,216 |
Title: Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
Issued: 27 October 2015 Assignee: Phosphagenics (ASX: POH) |
Description: This patent covers phosphate derivatives to improve transdermal drug delivery.
|
US Patent 9,163,081 |
Description: This patent covers antibodies to a cancer and inflammation target called midkine.
|
US Patent 9,163,029 |
Title: Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
Issued: 20 October 2015 Assignee: Biota |
Description: This patent covers small molecules for the treatment of RSV infection.
|
US Patent 9,163,018 |
Title: Method of treatment of age-related macular degeneration (AMD)
Issued: 20 October 2015 Assignee: Prana Biotechnology (ASX: PBT) |
Description: This patent covers a suite of metal-protein attenuating compounds useful in treating AMD.
|
US Patent 9,162,985 |
Title: Salts and solvates of a tetrahydroisoquinoline derivative
Issued: 20 October 2015 Assignee: Spinifex Pharmaceuticals |
Description: This patent covers a suite of angiotensin II type 2 receptor antagonists.
|
US Patent 9,161,923 |
Title: Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
Issued: 20 October 2015 Assignee: Brian Holden Vision Institute |
Description: This patent covers a contact lens formulation containing Dexpanthenol to prevent conjunctivitis.
|
US Patent 9,161,562 |
Title: Natural sweetener
Issued: 20 October 2015 Assignee: Horizon Science Pty Ltd (David Kannar and Barry Kitchen) |
Description: This patent covers a molasses extract.
|
US Patent 9,157,054 |
Title: Device and method for preparing microparticles
Issued: 13 October 2015 Assignee: University of Queensland |
Description: This patent covers a continuous method to produce microgel particles that can be used to encapsulate functional ingredients or drugs.
|
US Patent 9,156,916 |
Title: Modulation of T helper cell-mediated immune responses
Issued: 13 October 2015 Assignee: University of Sydney (50%), Northern Sydney and Central Coast Area Health Service (50%) |
Description: This patent covers the use of surface membrane IgD antagonists to suppress Th1 immune components.
|
US Patent 9,156,855 |
Title: Regulation of nitric oxide release and biofilm development
Issued: 13 October 2015 Assignee: University of New South Wales (50%), University of Wollongong (50%) |
Description: This patent covers the use of nitric oxide with and antimicrobial agents to disperse biofilms created byPseudomonas aeruginosa.
|
US Patent 9,150,621 |
Title: Mutant bacterial glycoproteins and uses thereof
Issued: 6 October 2015 Assignee: University of Queensland |
Description: This patent covers the use of bacteria as immunogens where certain glycoproteins have been pulled off the bacteria.
|
US Patent 9,150,619 |
Title: Method of elicting or inducing an immune response
Issued: 6 October 2015 Assignee: CSL Ltd (ASX: CSL) (50%), University of Melbourne (50%) |
Description: This patent covers the use of CSL's Iscomatrix adjuvant for intra-lung delivery of vaccines.
|
US Patent 9,149,452 |
Title: Methods and compositions for promoting the neurological development of an infant
Issued: 6 October 2015 Assignee: Women's & Children's Health Research Institute |
Description: This patent covers the use fatty acids high in docosahexaenoic acid as brain food for babies.
|
US Patent 9,145,375 |
Description: This patent covers the use of quinazolinone compounds for the treatment of Parkinson's Disease.
|
US Patent 9,139,879 |
Title: TAM receptors and TAM receptor ligands in detection and modulation of neuropathological disease
Issued: 22 September 2015 Assignee: Florey Institute of Neuroscience and Mental Health |
Description: This patent covers the use of TAM receptors for the treatment of Multiple Sclerosis.
|
US Patent 9,134,311 |
Title: Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
Issued: 15 September 2015 Assignee: Walter and Eliza Hall Institute |
Description: This patent covers a potential malaria vaccine based on a ligand which the malaria parasite uses to enter into erythrocytes.
|
US Patent 9,133,188 |
Description: This patent covers methods to scale-up production of Bionomics's anti-anxiolytic drug.
|
US Patent 9,131,681 |
Title: Particles comprising a releasable dopant therein
Issued: 15 September 2015 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers a method to include a dopant, such as a hydrophobic material, into solid or gel particles without the use of toxic solvents.
|
US Patent 9,127,130 |
Title: Polylysine dendrimer contrast agent
Issued: 8 September 2015 Assignee: Starpharma (ASX: SPL) (50%), Baker IDI Heart And Diabetes Institute (50%) |
Description: This patent covers a contrast agent made out of Starpharma's dendrimers.
|
US Patent 9,127,057 |
Title: Anti-IL-23 heterodimer specific antibodies
Issued: 8 September 2015 Assignee: Teva Pharmaceuticals Australia |
Description: This patent covers antibodies to Interleukin 23, an autoimmune disease target.
|
US Patent 9,125,943 |
Description: This patent covers CSL's reconstituted HDL, useful for the treatment of Acute Coronary Syndrome.
|
US Patent 9,125,853 |
Description: This patent covers a vaccine against Porphyromonas gingivalis.
|
US Patent 9,122,778 |
Description: This patent covers the use of immune system cycles for optimal chemotherapy.
|
US Patent 9,120,775 |
Description: This patent covers small molecule inhibitors of HCV polymerase.
|
US Patent 9,119,833 |
Title: Administration of relaxin to treat nephrogenic diseases of water imbalance involving acquaporin-4
Issued: 1 September 2015 Assignee: University of Melbourne (50%), University of Florida (US, 50%) |
Description: This patent covers the use of relaxin to treat kidney disease.
|
US Patent 9,119,818 |
Title: Use of angiogenin or angiogenin agonists for treating diseases and disorders
Issued: 1 September 2015 Assignee:Murray Goulburn Co-Operative (50%), Agriculture Victoria Services (50%) |
Description: This patent covers milk enriched for angiogenin, a peptide with anti-inflammatory and anti-microbial properties.
|
US Patent 9,119,805 |
Title: Therapy and prevention of problem drinking
Issued: 1 September 2015 Assignee: University of Sydney |
Description: This patent covers the use of oxytocin in treating alcohol addiction.
|
US Patent 9,119,394 |
Title: Anti-microbial polymers and their compositions
Issued: 1 September 2015 Assignee: Recce (ASX: RCE) |
Description: This patent covers polymers of acrolein for the treatment of bacterial infections.
|
US Patent 9,115,363 |
Title: Gene expression and eradication system in Helicobacter pylori
Issued: 25 August 2015 Assignee: Ondek |
Description: This patent covers the use of H. pylori as a tool for biological delivery vehicle for peptides
|
US Patent 9,110,061 |
Title: Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
Issued: 18 August 2015 Assignee: Cellestis |
Description: This patent covers genes from M. tuberculosis used as a tuberculosis diagnostic.
|
US Patent 9,109,040 |
Title: Treatment and prevention of malaria
Issued: 18 August 2015 Assignee: Walter and Eliza Hall Institute |
Description: This patent covers ligand which the malaria parasite uses to enter into erythrocytes.
|
US Patent 9,107,811 |
Title: Composition for treating skin lesions
Issued: 18 August 2015 Assignee: Sci-Chem International Pty Ltd |
Description: This patent covers a combination of copper and Hypericum perforatum extract to treat skin lesions.
|
US Patent 9,101,732 |
Title: Drug-delivery accessory for an implantable medical device
Issued: 11 August 2015 Assignee: Cochlear (ASX: COH) |
Description: This patent covers a device to allow neural drug delivery alongside implantation of a cochlear implant.
|
US Patent 9,101,650 |
Title: Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
Issued: 11 August 2015 Assignee: Paradigm Biopharma (ASX: PAR) |
Description: This patent covers the use of polysulphate sodium in treating bone marrow edema.
|
US Patent 9,095,587 |
Title: Methods and compositions for improved nerve conduction velocity
Issued: 4 August 2015 Assignee: Spinifex Pharmaceuticals |
Description: This patent covers the use of an angiotensin II type 2 receptor antagonist to improve nerve conduction velocities.
|
US Patent 9,095,524 |
Description: This patent covers a three-dimensional nanofiber webbing used in the treatment of AMD.
|
US Patent 9,095,519 |
Title: Dosage form containing two or more active pharmaceutical ingredients in different physical forms
Issued: 4 August 2015 Assignee: Alphapharm Pty Ltd |
Description: This patent covers a method of combining APIs in a drug formulation for that the two APIs can be easily separated for analytical testing.
|
US Patent 9,090,706 |
Title: Fibronectin: growth factor chimeras
Issued: 28 July 2015 Assignee: Queensland University of Technology |
Description: This patent covers combinations of fibronectin and growth factors such as IGF-I, useful in tissue repair.
|
US Patent 9,089,508 |
Title: Method of transfection and compositions therefor
Issued: 28 July 2015 Assignee: University of Melbourne |
Description: This patent covers the use of bacterial cell wall lipid called Pam2Cys for targeted delivery of molecules to cells expressing toll-like receptors
|
US Patent 9,085,770 |
Title: Delivery of dsRNA to arthropods
Issued: 21 July 2015 Assignee: Commonwealth Scientific and Industrial Research Organisation |
Description: This patent covers a gene silencing technique
|
US Patent 9,085,628 |
Title: Antibody molecule for human GM-CSF receptor alpha
Issued: 21 July 2015 Assignee: CSL Ltd (ASX: CSL) (50%), Medimmune (US, 50%) |
Description: This patent covers antibodies to GM-CSF-alpha, useful in treating autoimmune diseases.
|
US Patent 9,084,827 |
Title: Biodegradable polyurethane/urea compositions
Issued: 21 July 2015 Assignee: Polynovo (ASX: PNV) |
Description: This patent covers a biodegradable polymer for use in tissue repair.
|
US Patent 9,084,770 |
Title: Modulation of insulin like growth factor I receptor expression in cancer
Issued: 21 July 2015 Assignee: Antisense Therapeutics (ASX: ANP) |
Description: This patent covers the use of IGF-I receptor antisense oligonucleotides in the treatment of cancer.
|
US Patent 9,079,967 |
Description: This patent covers chaperonin 10 polypeptides, useful for activating Toll-Like Receptors.
|
US Patent 9,079,950 |
Description: This patent covers a modified HCV E2 protein that allows better structural and functional studies of HCV.
|
US Patent 9,078,845 |
Description: This patent covers a combination of alpha-linolenic acid and tea tree oil useful as an anti-microbial.
|
US Patent 9,078,816 |
Title: Buccal, polar and non-polar spray containing ondansetron
Issued: 14 July 2015 Assignee: Suda Ltd (ASX: SUD) |
Description: This patent covers a buccal spray for the delivery of the nausea drug ondansetron.
|
US Patent 9,078,810 |
Description: This patent covers a transdermal drug delivery penetration enhancer based on salicylic acid and polyethylene glycol.
|
US Patent 9,073,997 |
Title: Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
Issued: 7 July 2015 Assignee: Opthea (ASX: OPT) |
Description: This patent covers antagonosts to VEGFR-3.
|
US Patent 9,066,982 |
Title: Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
Issued: 30 June 2015 Assignee: EnGeneIC |
Description: This patent covers bacterially derived 'minicells' containing functional nucleic acids for gene therapy.
|
US Patent 9,066,919 |
Title: Hyaluronan as a chemo-sensitizer in the treatment of cancer
Issued: 30 June 2015 Assignee: Alchemia (ASX: ACL) |
Description: This patent covers the use of hyaluronic acid to better target cancer drugs.
|
US Patent 9,066,526 |
Title: Allergy treatment using acid treated aqueous whey protein extract
Issued: 30 June 2015 Assignee: Dairy Australia |
Description: This patent covers acid treated whey protein as a treatment for allergies.
|
US Patent 9,063,155 |
Title: Immunotherapeutic method of treating neoplastic conditions
Issued: 23 June 2015 Assignee: Medvet Science Pty Ltd |
Description: This patent covers antibodies to the La antigen, indicative of an apoptotic cell.
|
US Patent 9,062,288 |
Title: Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes
Issued: 23 June 2015 Assignee: Regeneus (ASX: RGS) |
Description: This patent covers adipose-derived mesenchymal stem cells for use in treating inflammatory disorders in animals.
|
US Patent 9,062,118 |
Title: J-superfamily conotoxin peptides
Issued: 23 June 2015 Assignee: University of Queensland (33%), University of Utah (US 33%), Max Planck Society (Germany 33%) |
Description: This patent covers conotoxins potential useful in disorders involving ion channels.
|
US Patent 9,062,013 |
Title: Positive allosteric modulators of the alpha.7 nicotinic acetylcholine receptor and uses thereof
Issued: 23 June 2015 Assignee: Bionomics (ASX: BNO) |
Description: This patent covers small molecules that target the nicotinic acetylcholine receptor, potentially useful in treating Alcheimer's and schizophrenia.
|
US Patent 9,062,013 |
Description: This patent covers peptide derived from relaxin useful in treatment of blood pressure and kidney issues.
|
US Patent 9,051,551 |
Title: Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors
Issued: 9 June 2015 Assignee: University of Western Australia |
Description: This patent covers the use of a microRNA called miR-7 to sensitive cancer cells to treatment tyrosine kinase inhibitors such as Erlotinib.
|
US Patent 9,051,369 |
Title: Avian cytokines and genetic sequences encoding same
Issued: 9 June 2015 Assignee: Commonwealth Scientific and Industrial Research Organisation |
Description: This patent covers chicken interferon gamma for treating avian disease.
|
US Patent 9,045,475 |
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Issued: 2 June 2015 Assignee: Walter and Eliza Hall Institute (33%), AbbVie (US, 33%), Genentech (US, 33%) |
Description: This patent covers small molecules that inhibit anti-apoptotic Bcl-2 proteins.
|
US Patent 9,045,452 |
Description: This patent covers various substituted nitrostyrene compounds with anti-microbial as well as radioprotective qualities.
|
US Patent 9,044,489 |
Description: This patent covers honey with non-peroxide antibacterial activity.
|
US Patent 9,040,503 |
Title: Medicinal carbohydrates for treatment of respiratory conditions
Issued: 26 May 2015 Assignee: Aus Bio Ltd |
Description: This patent covers glycoproteins to restore sialylglycoconjugates on the surface of the respiratory cell.
|
US Patent 9,035,028 |
Title: Temperature sensitive conjugate compositions
Issued: 19 May 2015 Assignee: Baker IDI Heart and Diabetes Institute (50%), Emory University (US, 50%) |
Description: This patent covers a temperature sensitive polymer conjugated to an single-chain antibidy to integrin GPIIb/IIIa to preserve platelet function during cardiopulmonary bypass.
|
US Patent 9,034,381 |
Description: This patent covers methods for maintaining particle size consistency in a drug formulation.
|
US Patent 9,034,378 |
Title: Biodegradable polyurethane and polyurethane ureas
Issued: 19 May 2015 Assignee: PolyNovo (ASX: PNV) |
Description: This patent covers a biodegradable polymer material.
|
US Patent 9,023,892 |
Description: This patent covers aryl compound with antibiotic properties.
|
US Patent 9,023,863 |
Description: This patent covers a transdermal foam for drug delivery.
|
US Patent 9,023,799 |
Title: Method to reduce loss of cardiac function following ischemia/reperfusion
Issued: 5 May 2015 Assignee: Cellmid (ASX: CDY) |
Description: This patent covers the use of midkine to treat reperfusion injury.
|
US Patent 9,018,247 |
Title: Compositions and products containing S-equol, and methods for their making
Issued: 28 April 2015 Assignee: Sanitarium (50%); Cincinnati Children's Hospital (United States, 50%) |
Description: This patent covers S-equol, an intestinally derived metabolite of the soy isoflavone daidzein. S-equol may be useful in enhancing the efficacy of soy diets.
|
US Patent 9,018,207 |
Description: This patent covers a suite of angiotensin II type 2 receptor antagonists.
|
US Patent 9,018,168 |
Title: Therapeutic method for treating congestive heart failure
Issued: 28 April 2015 Assignee: Madeleine Pharmaceuticals |
Description: This patent covers a derivative of atrial natriuretic peptide for the treatment of heart failure.
|
US Patent 9,017,697 |
Title: Compositions and methods for modulating immune responses
Issued: 28 April 2015 Assignee: University of Queensland |
Description: This patent covers an NF-κB inhibitor.
|
US Patent 9,017,643 |
Title: Particles comprising a releasable dopant therein
Issued: 28 April 2015 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers a method to include a dopant, such as a hydrophobic material, into solid or gel particles without the use of toxic solvents.
|
US Patent 9,011,878 |
Title: Vaccine strains of Brachyspira hyodysenteriae
Issued: 21 April 2015 Assignee: Spirogene Pty Ltd |
Description: This patent covers live vaccine strains for the intestinal spirochaete B. hyodysenteriae.
|
US Patent 9,006,397 |
Description: This patent covers antibodies to Fibroblast Growth Factor Inducible 14 , relevant in the treatment of cachexia.
|
US Patent 9,006,284 |
Title: Combination therapy for treating proliferative diseases
Issued: 14 April 2015 Assignee: Bionomics (ASX: BNO) |
Description: This patent covers the combination of a tubulin polymerisation inhibitor and an mTOR inhibitor for the treatment of cancer.
|
US Patent 9,006,200 |
Title: MicroRNA-based approach to treating malignant pleural mesothelioma
Issued: 14 April 2015 Assignee: Asbestos Diseases Research Institute |
Description: This patent covers microRNA mimics, corresponding to the miR-15/107 family potentially useful in the treatment of mesothelioma.
|
US Patent 8,999,920 |
Title: Reconstituted high density lipoprotein formulation and production method thereof
Issued: 7 April 2015 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers CSL's reconstituted HDL, useful for the treatment of Acute Coronary Syndrome.
|
US Patent 8,999,353 |
Title: Method of eliciting an immune response against pandemic influenza virus
Issued: 7 April 2015 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers the use of CSL's Iscomatrix adjuvant in creating an H5N1 virus.
|
US Patent 8,993,635 |
Title: Method of increasing or maintaining the reproductive performance of sows
Issued: 31 March 2015 Assignee: Pork CRC |
Description: This patent covers the use of ractopamine in maintaining the reproductive performance of sows.
|
US Patent 8,993,520 |
Title: Method and composition for transdermal drug delivery
Issued: 31 March 2015 Assignee: Acrux (ASX: ACR) |
Description: This patent covers the use octyl salicylate as a penetration enhancer.
|
US Patent 8,992,986 |
Title: Controlled release of biological entities
Issued: 31 March 2015 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers a ceramic encapsulant used for drug delivery.
|
US Patent 8,992,982 |
Description: This patent covers a formulation of indomethacin using a drug milling process for smaller particle size.
|
US Patent 8,992,935 |
Title: Means of controlling infection persistence of Helicobacter pylori
Issued: 31 March 2015 Assignee: Ondek |
Description: This patent covers a genetically modified H. pylori as a vaccine strain.
|
US Patent 8,986,700 |
Title: Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes
Issued: 24 March 2015 Assignee: Queensland Institute of Medical Research |
Description: This patent covers lipopeptides for making self-adjuvanting peptide vaccines.
|
US Patent 8,980,914 |
Description: This patent covers 7-aminoquinolinone derivative for the treatment of COPD.
|
US Patent 8,975,278 |
Title: 8-hydroxy quinoline derivatives
Issued: 10 March 2015 Assignee: Prana Biotechnology (ASX: PBT) |
Description: This patent covers a suite of metal-protein attenuating compounds useful in treating Alzheimer's.
|
US Patent 8,975,245 |
Description: This patent a clear aqueous solution of the neuroactive steroid anaesthetic Alphaxalone.
|
US Patent 8,974,803 |
Description: This patent covers injectable tropoelastin for tissue repair.
|
US Patent 8,968,731 |
Description: This patent covers antibodies to G-CSF Receptor for the treatment of uveitis.
|
US Patent 8,962,830 |
Title: Protein kinase inhibitors and methods of treatment
Issued: 24 February 2015 Assignee: Walter and Eliza Hall Institute |
Description: This patent covers Src family kinase inhibitors.
|
US Patent 8,962,801 |
Description: This patent covers proteins from Neisseria meningitidis suitable for a vaccine construct.
|
US Patent 8,962,649 |
Title: Multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical
Issued: 24 February 2015 Assignee: iNova Pharmaceuticals |
Description: This patent covers the packaging for an imiquimod formulation.
|
US Patent 8,960,128 |
Description: This patent covers a topical anesthetic for applications such as mulesing of sheep.
|
US Patent 8,957,099 |
Description: This patent covers the use of sodium valproate in the treatment of ADHD.
|
US Patent 8,956,864 |
Title: Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
Issued: 17 February 2015 Assignee: EnGeneIC |
Description: This patent covers 'minicells' for the delivery of nucleic acid into cells.
|
US Patent 8,951,543 |
Description: This patent covers a silver-zinc formation with anti-microbial properties.
|
US Patent 8,946,381 |
Title: Compositions and uses thereof for the treatment of wounds
Issued: 3 February 2015 Assignee: Phylogica (ASX: PYC), McComb Foundation. |
Description: This patent covers an AP-1 signaling inhibitor for the treatment of wounds.
|
US Patent 8,946,146 |
Description: This patent covers an inhibitor of macrophage inhibitory cytokine-1 (MIC-1) for weight loss.
|
US Patent 8,945,551 |
Description: This patent covers a biopolymer gel used for controlled release of drugs.
|
US Patent 8,940,695 |
Title: Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
Issued: 27 January 2015 Assignee: Opthea (ASX: OPT) |
Description: This patent covers the cancer target VEGFR-3 as well as antibodies to it.
|
US Patent 8,939,932 |
Description: This patent covers a device for delivery of a viral inactivation agent in HPV infection.
|
US Patent 8,937,052 |
Description: This patent covers the use of hyaluron as a vehicle for targeted delivery of cancer drugs.
|
US Patent 8,933,092 |
Title: Methods and compositions comprising sequential administration opioid receptor agonists
Issued: 13 January 2015 Assignee: QRXPharma |
Description: This patent covers the combination of morphine and oxycodone for pain management.
|
US Patent 8,933,033 |
Description: This patent covers chaperonin 10 polypeptides, useful for activating Toll-Like Receptors.
|
US Patent 8,933,027 |
Title: Method of treating a disease or condition characterised by aberrant epithelial cell proliferation
Issued: 13 January 2015 Assignee: Queensland University of Technology |
Description: This patent covers combinations of fibronectin and IGF-I, useful in tissue repair.
|
US Patent 8,932,588 |
Title: Treatment of cancer involving mutated KRAS or BRAF genes
Issued: 13 January 2015 Assignee: Teva Pharmaceuticals Australia |
Description: This patent covers a monoclonal antibody to colon cancer where the cancer has KRAS and BRAF mutants.
|
US Patent 8,927,575 |
Title: Salts and solvates of a tetrahydroisoquinoline derivative
Issued: 6 January 2015 Assignee: Spinifex Pharmaceuticals |
Description: This patent covers angiotensin receptor blockers
|
US Patent 8,927,565 |
Title: Compositions for veterinary and medical applications
Issued: 6 January 2015 Assignee: Aus Bio Ltd |
Description: This patent covers the use of berberine chloride in the treatment of gastrointestinal disorders
|
US Patent 8,927,503 |
Title: Modulations of protease activated receptors
Issued: 6 January 2015 Assignee: University of Queensland |
Description: This patent covers antagonists to a GPCR called Protease activated receptor-2.
|
Copyright © 2016 NDF Research